19.10 USD
↗ 0.61 (3.30%)AT CLOSE (03:59 PM EST)
GH Research PLC Ordinary Shares
GHRSNASDAQ • USD
18.47
↘ 0.64 (3.32%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
18.47
↘ 0.64 (3.32%)
Market: CLOSED
GH Research PLC Ordinary Shares (GHRS) trades at $19.10 per share. Technical indicators currently signal "Neutral". This is driven by a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Nov 13, 2026.
Open?$18.84
High?$19.81
Low?$18.00
Prev. Close?$18.49
Volume?560.2K
Avg. Volume?N/A
VWAP?$19.31
Bid / Ask
Bid?$16.02 × 100
Ask?$23.00 × 100
Spread?$6.98
Midpoint?$19.51
Valuation & Ratios
Market Cap?1.3B
Shares Out?68.6M
Float?44.1M
Float %?64.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?4.71%Low
Short Interest?2.1M
Days to Cover?6.5
Free Float44.1M
Avg Daily Volume319.4K
Settlement Date2026-10-30